CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial

Expert OpinionVolume 13, Issue 1 Part 2, January 2020

JOURNAL:JACC: Cardiovascular Imaging Article Link

Noninvasive Imaging for the Evaluation of Diastolic Function: Promises Fulfilled

SF Nagueh, Y Chandrashekhar. Keywords: noninvasive Imaging; heart failure; Left ventricular diastolic function

FULL TEXT PDF